Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-enriched Rheumatoid Arthritis Patients
Related Posts
Zhou FF, Essien UR, Souza JM, Sarkisian CA, Damberg CL, Landon BE, Mafi JN. Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries. JAMA Netw[...]
Higashi RT, Thakur B, Repasky EC, Casillas A, Steitz BD, Hogan TP, Lehmann CU, Peterson ED, Navar AM, Turer RW. Digital Health Technology Use Among[...]
Nikitas J, Ballas LK, Romero T, Lynch C, Ma TM, Valle LF, Sachdeva A, Chong N, Basehart V, Franco A, Reiter R, Saigal C, Chamie[...]